Scarica l'app Stockscreener
109.56
0.57%
0.62
Dopo l'orario di chiusura:
109.57
0.010
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$108.94
Aprire:
$108.99
Volume 24 ore:
1.04M
Relative Volume:
0.73
Capitalizzazione di mercato:
$21.81B
Reddito:
$7.60B
Utile/perdita netta:
$1.08B
Rapporto P/E:
20.83
EPS:
5.26
Flusso di cassa netto:
$1.26B
1 W Prestazione:
+4.80%
1M Prestazione:
+1.39%
6M Prestazione:
-1.34%
1 anno Prestazione:
-10.37%
Intervallo 1D:
$108.47
$109.97
Intervallo di 1 settimana:
$103.14
$109.97
Portata 52W:
$100.67
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
109.56 | 21.81B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
What to Expect From Zimmer Biomet’s Q4 2024 Earnings Report - Nasdaq
Is Zimmer Biomet (ZBH) an Undervalued Defensive Stock for 2025? - Insider Monkey
What To Expect From Zimmer Biomet’s Q4 2024 Earnings Report - Barchart
Gateway Investment Advisers LLC Has $648,000 Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Border to Coast Pensions Partnership Ltd Boosts Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory - MSN
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results - Kilgore News Herald
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Bernzott Capital Advisors - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Meyer Handelman Co. Sells 3,180 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
JP Morgan 2025: Zimmer Biomet bullish on a strong market return in 2025 - Yahoo Finance
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Peddock Capital Advisors LLC Makes New Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Reinhart Partners LLC. - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by ORG Partners LLC - MarketBeat
ST Germain D J Co. Inc. Trims Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
NeuroOne Medical Revenue Surges 520% to Record $6.2M, Boosted by Zimmer Biomet Deal - StockTitan
Autologous Conditioned Plasma Market Poised for 11.6% CAGR Growth through 2034 | Fact.MR Report - GlobeNewswire Inc.
Bunion correction systems Market Key Players AnalysisStryker - openPR
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Douglas Lane & Associates LLC - MarketBeat
Zimmer Biomet (NYSE:ZBH) Sets New 12-Month LowHere's Why - MarketBeat
Dental Crowns and Bridges Market Trends and Growth Forecast - GlobeNewswire
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2023 - GuruFocus.com
Zimmer Biomet Announces Key Updates to Company's Executive Leade - GuruFocus.com
Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook - Seeking Alpha
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Oversold Conditions For Zimmer Biomet Holdings (ZBH) - Nasdaq
Zimmer Biomet price target raised to $113 from $110 at Evercore ISI - Yahoo Finance
ZIMMER BIOMET HOLDINGS, INC. - Marketscreener.com
Zimmer Biomet: The Valuation Discount Is Not Justified - Yahoo Finance
Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant - AboutLawsuits.com
ZBH Stock to Benefit From Global Expansion Despite Macro Issues - Yahoo Finance
Zimmer Biomet Holdings (NYSE:ZBH) Could Be A Buy For Its Upcoming Dividend - Simply Wall St
Principal Financial Group Inc. Trims Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024 - The Eastern Progress Online
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthca - GuruFocus.com
How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks? - MSN
Zimmer Biomet to Present at J.P. Morgan Healthcare Conference 2025: Key Insights Coming - StockTitan
Zimmer Biomet receives FDA 510(k) clearance for stemless total shoulder replacement system - Healio
Zimmer Biomet price target raised to $118 from $117 at Truist - Yahoo Finance
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024 - The Malaysian Reserve
Total Wrist Replacement Market Top PlayersZimmer Biomet, - openPR
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.25%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):